News

We invest in growth stage diagnostic companies and empower them with the full strength of our collective resources, capital, and expertise.

Satio completes development, testing of remotely controllable, at-home intradermal drug delivery system

READ MORE

Sapphiros Secures Additional NIH RADx® Support to Advance Next-Gen Molecular Respiratory At-Home Diagnostic

READ MORE

Sapphiros Appoints Healthcare Executive Jackson McAdam as Chief Financial Officer

READ MORE

Sapphiros Launches NowFuture™: A New Era in Personalized Wellness

READ MORE

Sapphiros Is Pleased To Announce OraSure Technologies, Inc. Secures Strategic Distribution Rights and Invests In Sapphiros

READ MORE

Sapphiros and Cencora, formerly AmerisourceBergen Corporation, Enter into Distribution Agreement

READ MORE